Adcock Ingram is South Africa’s second largest drug maker. It has a market cap of R10.5 billion, a PE of 19.42 and a dividend yield of 2.32per cent. Guest Nesan Nair, Sasfin Securities and resident expert Paul Theron from Vestact decide whether Adcock Ingram is hot or not.